Literature DB >> 31687756

The Use of Large-Particle Aerosol Exposure to Nipah Virus to Mimic Human Neurological Disease Manifestations in the African Green Monkey.

Ji Hyun Lee1, Dima A Hammoud2, Yu Cong1, Louis M Huzella1, Marcelo A Castro1, Jeffrey Solomon3, Joseph Laux1, Matthew Lackemeyer1, J Kyle Bohannon1, Oscar Rojas1, Russ Byrum1, Ricky Adams1, Danny Ragland1, Marisa St Claire1, Vincent Munster4, Michael R Holbrook1.   

Abstract

Nipah virus (NiV) is an emerging virus associated with outbreaks of acute respiratory disease and encephalitis. To develop a neurological model for NiV infection, we exposed 6 adult African green monkeys to a large-particle (approximately 12 μm) aerosol containing NiV (Malaysian isolate). Brain magnetic resonance images were obtained at baseline, every 3 days after exposure for 2 weeks, and then weekly until week 8 after exposure. Four of six animals showed abnormalities reminiscent of human disease in brain magnetic resonance images. Abnormalities ranged from cytotoxic edema to vasogenic edema. The majority of lesions were small infarcts, and a few showed inflammatory or encephalitic changes. Resolution or decreased size in some lesions resembled findings reported in patients with NiV infection. Histological lesions in the brain included multifocal areas of encephalomalacia, corresponding to known ischemic foci. In other regions of the brain there was evidence of vasculitis, with perivascular infiltrates of inflammatory cells and rare intravascular fibrin thrombi. This animal model will help us better understand the acute neurological features of NiV infection and develop therapeutic approaches for managing disease caused by NiV infection. Published by Oxford University Press for the Infectious Diseases Society of America 2019.

Entities:  

Keywords:  Computed tomography; Magnetic resonance imaging; Nipah virus; Paramyxovirus; pathology

Mesh:

Substances:

Year:  2020        PMID: 31687756      PMCID: PMC7368178          DOI: 10.1093/infdis/jiz502

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates.

Authors:  Justin M Hartings; Chad J Roy
Journal:  J Pharmacol Toxicol Methods       Date:  2004 Jan-Feb       Impact factor: 1.950

2.  The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia.

Authors:  K B Chua; S K Lam; K J Goh; P S Hooi; T G Ksiazek; A Kamarulzaman; J Olson; C T Tan
Journal:  J Infect       Date:  2001-01       Impact factor: 6.072

3.  Nipah viral encephalitis or Japanese encephalitis? MR findings in a new zoonotic disease.

Authors:  C C Lim; Y Y Sitoh; F Hui; K E Lee; B S Ang; E Lim; W E Lim; H M Oh; P A Tambyah; J S Wong; C B Tan; T S Chee
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

4.  Ground-glass opacity of the lung parenchyma: a guide to analysis with high-resolution CT.

Authors:  C E Engeler; J H Tashjian; S W Trenkner; J W Walsh
Journal:  AJR Am J Roentgenol       Date:  1993-02       Impact factor: 3.959

5.  Nipah encephalitis - an update.

Authors:  B A Sherrini; T T Chong
Journal:  Med J Malaysia       Date:  2014-08

6.  Nipah virus encephalitis outbreak in Malaysia.

Authors:  Sai Kit Lam; Kaw Bing Chua
Journal:  Clin Infect Dis       Date:  2002-05-01       Impact factor: 9.079

7.  Clinical presentation of nipah virus infection in Bangladesh.

Authors:  M Jahangir Hossain; Emily S Gurley; Joel M Montgomery; Michael Bell; Darin S Carroll; Vincent P Hsu; P Formenty; A Croisier; E Bertherat; M A Faiz; Abul Kalam Azad; Rafiqul Islam; M Abdur Rahim Molla; Thomas G Ksiazek; Paul A Rota; James A Comer; Pierre E Rollin; Stephen P Luby; Robert F Breiman
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

8.  Long-term neurological and functional outcome in Nipah virus infection.

Authors:  James J Sejvar; Jahangir Hossain; Sankar Kama Saha; Emily S Gurley; Shakila Banu; Jena D Hamadani; Mohammed Abdul Faiz; F M Siddiqui; Quazi Deen Mohammad; Abid Hossain Mollah; Rafique Uddin; Rajibul Alam; Ridwanur Rahman; Chong Tin Tan; William Bellini; Paul Rota; Robert F Breiman; Stephen P Luby
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

9.  Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.

Authors:  Chad E Mire; Benjamin A Satterfield; Joan B Geisbert; Krystle N Agans; Viktoriya Borisevich; Lianying Yan; Yee-Peng Chan; Robert W Cross; Karla A Fenton; Christopher C Broder; Thomas W Geisbert
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

10.  Nipah virus-associated encephalitis outbreak, Siliguri, India.

Authors:  Mandeep S Chadha; James A Comer; Luis Lowe; Paul A Rota; Pierre E Rollin; William J Bellini; Thomas G Ksiazek; Akhilesh Mishra
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

View more
  3 in total

Review 1.  Henipavirus Immune Evasion and Pathogenesis Mechanisms: Lessons Learnt from Natural Infection and Animal Models.

Authors:  Philip Lawrence; Beatriz Escudero-Pérez
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

2.  Detailed analysis of the pathologic hallmarks of Nipah virus (Malaysia) disease in the African green monkey infected by the intratracheal route.

Authors:  Curtis Cline; Todd M Bell; Paul Facemire; Xiankun Zeng; Thomas Briese; W Ian Lipkin; Joshua D Shamblin; Heather L Esham; Ginger C Donnelly; Joshua C Johnson; Lisa E Hensley; Anna N Honko; Sara C Johnston
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

Review 3.  Drivers and Distribution of Henipavirus-Induced Syncytia: What Do We Know?

Authors:  Amandine Gamble; Yao Yu Yeo; Aubrey A Butler; Hubert Tang; Celine E Snedden; Christian T Mason; David W Buchholz; John Bingham; Hector C Aguilar; James O Lloyd-Smith
Journal:  Viruses       Date:  2021-09-02       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.